{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-105831","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2022-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.636419+00:00","generated_at":"2026-06-23T05:41:08.134480+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Anzu Special Acquisition Corp I expands board to five, appoints Hirsch as CFO and Dewbrey as director","bullets":["Board increased from 3 to 5 directors; Hirsch and Dewbrey appointed as directors effective Oct 1, 2022.","Hirsch named CFO and Corporate Secretary; previously COO/CFO of Cascade Acquisition Corp.","Dewbrey determined independent, appointed to Audit, Compensation, Nominating committees and chair of Compensation.","Sponsor transferred 25,000 Class B shares to each new director.","Indemnification agreements entered with Hirsch and Dewbrey."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-105831","json":"https://secwatch.observer/filing/0001104659-22-105831.json","markdown":"https://secwatch.observer/filing/0001104659-22-105831.md","text":"https://secwatch.observer/filing/0001104659-22-105831.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000110465922105831/0001104659-22-105831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000110465922105831/tm2227306d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:41:08.134480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ae72d394b","claim":"Daniel J. Hirsch was appointed as Chief Financial Officer and Corporate Secretary at Envoy Medical, Inc..","evidence_excerpt":"the Board appointed Mr. Hirsh as the Chief Financial Officer and Corporate Secretary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000110465922105831/0001104659-22-105831-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}